scispace - formally typeset
O

Olivier Cottencin

Researcher at university of lille

Publications -  173
Citations -  4008

Olivier Cottencin is an academic researcher from university of lille. The author has contributed to research in topics: Alcohol dependence & Catatonia. The author has an hindex of 32, co-authored 164 publications receiving 3505 citations. Previous affiliations of Olivier Cottencin include Centre national de la recherche scientifique.

Papers
More filters
Journal ArticleDOI

Supervised injection services: What has been demonstrated? A systematic literature review

TL;DR: SISs have largely fulfilled their initial objectives without enhancing drug use or drug trafficking, and the implementation of new SISs in places with high rates of injection drug use and associated harms appears to be supported by evidence.
Journal ArticleDOI

Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: A double-blind, randomized, placebo-controlled study

TL;DR: Whether antidepressants provide real benefits and whether tricyclic and selective serotonin reuptake inhibitor (SSRI) antidepressants differ in their short‐term efficacy is investigated, because the time to onset of therapeutic benefit remains an important criterion in depression.
Journal ArticleDOI

Synthetic Cathinones: A New Public Health Problem

TL;DR: The major clinical effects of synthetic cathinones are reviewed to highlight their impact on public health.
Journal ArticleDOI

Sexual addiction or hypersexual disorder: different terms for the same problem? A review of the literature.

TL;DR: A systematic review of the existing measures for sexual addiction found that people who were categorized as having a compulsive, impulsive, addictive sexual disorder or a hypersexual disorder reported having obsessive thoughts and behaviors as well as sexual fantasies.
Journal ArticleDOI

Off-Label Prescribing of Antipsychotics in Adults, Children and Elderly Individuals: A Systematic Review of Recent Prescription Trends.

TL;DR: OLP is often used in cases of therapeutic dead-ends or for specific disorders with few or no currently approved medications, however, other OLP practices only reflect temporary prescription trends for mild symptoms, which may induce safety concerns.